Cargando…

Is it Time for Single-Pill Combinations in Dyslipidemia?

Despite the availability of lipid-lowering therapies (LLTs) that are safe and effective, the overall rate of low-density lipoprotein cholesterol (LDL-C) control at a population level in real-life studies is low. Higher-intensity treatment, earlier intervention, and longer-term treatment have all bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiele, François, Pérez de Isla, Leopoldo, Arca, Marcello, Vlachopoulos, Charalambos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061650/ https://www.ncbi.nlm.nih.gov/pubmed/34549371 http://dx.doi.org/10.1007/s40256-021-00498-2

Ejemplares similares

Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study
por: Wilke, Thomas, et al.
Publicado: (2022)

EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
por: Naydenov Naydenov, Stefan, et al.
Publicado: (2018)

Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
por: Choi, JungMin, et al.
Publicado: (2021)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient
por: Sarzani, Riccardo, et al.
Publicado: (2022)

Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development
por: Paczkowska-Walendowska, Magdalena, et al.
Publicado: (2022)

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
por: Burnier, Michel
Publicado: (2010)

Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
por: Billecke, Scott S, et al.
Publicado: (2013)

Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy
por: Rea, Federico, et al.
Publicado: (2023)

Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
por: Zeng, Rui, et al.
Publicado: (2016)

Hypertension and Dyslipidemia Combined Therapeutic Approaches
por: Borghi, Claudio, et al.
Publicado: (2022)

A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide
por: Segura, Julian, et al.
Publicado: (2013)

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Efficacy of single‐pill combination in uncontrolled essential hypertension: A systematic review and network meta‐analysis
por: Xie, Mengxin, et al.
Publicado: (2023)

Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations
por: Burnier, Michel, et al.
Publicado: (2023)

Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis
por: Weisser, Burkhard, et al.
Publicado: (2020)

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
por: Rea, Federico, et al.
Publicado: (2021)

Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice
por: Filipiak, Krzysztof J., et al.
Publicado: (2022)

Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination
por: Aslam, Farhan, et al.
Publicado: (2009)

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
por: Chilbert, Maya R, et al.
Publicado: (2022)

Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
por: Patel, Bimal V, et al.
Publicado: (2008)

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
por: Liu, Huixing, et al.
Publicado: (2022)

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine
por: Motozato, Kota, et al.
Publicado: (2016)

THE CONTRACEPTIVE PILL
Publicado: (1965)

Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?
por: Tonk, Christian Horst, et al.
Publicado: (2022)

Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?
por: Li, Yanglong, et al.
Publicado: (2021)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension
por: Mende, Christian W., et al.
Publicado: (2017)

The Effects of Single Pill Combinations on Adherence and Blood Pressure Control in Hypertensive Patients
por: Naser, Nabil, et al.
Publicado: (2022)

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin
por: Richard Hobbs, FD
Publicado: (2007)

Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept
por: Vlachopoulos, Charalambos, et al.
Publicado: (2015)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

Estimating the impact of single pill combination therapy for hypertension: projections of patient outcomes in Italy
por: Borghi, Claudio, et al.
Publicado: (2023)

Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case–Control Analysis
por: Nowak, Emmanuel, et al.
Publicado: (2015)

Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform
por: Volpe, Massimo, et al.
Publicado: (2017)

Treatment of dyslipidemia
por: Tonkin, Andrew, et al.
Publicado: (2014)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2uknlsuqhdf0h9sqvanuu08pa1